Metagenomi, Inc. (MGX)
(Delayed Data from NSDQ)
$2.23 USD
-0.07 (-3.04%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $2.22 -0.01 (-0.45%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MGX 2.23 -0.07(-3.04%)
Will MGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MGX
BeOne Medicines Ltd. - Sponsored ADR (ONC) Surges 4.0%: Is This an Indication of Further Gains?
Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates
MGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates
What Makes Metagenomi (MGX) a New Buy Stock
Other News for MGX
Sam Altman Says He 'Didn't Think' Elon Musk Would Abuse Government Power, Tesla CEO Hits Back With 'Scam Altman' Jibe
Oracle Surges with Strong Q4 Earnings and Promising Future Growth
OpenAI Looks To Raise $40 Billion From Global Investors Including Saudi Arabia's PIF, India's Reliance Industries To Accelerate AI Models And Stargate: Report
Metagenomi, Inc. Holds Annual Stockholders Meeting
Metagenomi, Inc. (MGX) Gets a Buy from H.C. Wainwright